the current role of acalabrutinib in the treatment of cll
Published 2 years ago • 584 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
0:55
acalabrutinib in patients with cll and mcl undergoing allosct
-
2:55
a model including cd49d expression to predict outcomes in patients with cll treated with ibrutinib
-
2:30
ascend: 3 year follow-up of acalabrutinib in r/r cll
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:25
hypertension prevalence in cll and how it is affected by acalabrutinib treatment
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
5:06
evolution of btk inhibitors in cll
-
4:34
arthur's story: his cll diagnosis. challenges, treatments and future hope.
-
0:38
pain management for patients with scd and thalassemia in lebanon
-
1:36
evaluating acalabrutinib in cll treatment
-
2:21
uk-based cll clinical trials to look forward to
-
1:28
the future of cll treatment
-
3:10
ascend: acalabrutinib in r/r cll
-
1:24
sequencing of btk inhibitors in cll
-
1:42
acalabrutinib in r/r cll: ascend results show tolerability and efficacy
-
1:16
current and future advancements in the treatment of cll
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:32
an update from bellwave-001: nemtabrutinib in cll/sll
-
9:00
overview of cll therapies and sequencing of therapies
-
1:01
update on the cll treatment landscape